Financial statements Biosecure
Company suspended its operations from 2025-08-12
Balance sheet data of BIOSECURE
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 433 147,46 | 184 907,31 | 191 350,84 | 179 891,27 | 144 066,77 |
| A. Fixed assets | 30 865,70 | 9 024,39 | 9 024,39 | 9 024,39 | 9 024,39 |
| B. Current assets | 402 281,76 | 175 882,92 | 182 326,45 | 170 866,88 | 135 042,38 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | - |
| D. Own shares (stocks) | 0,00 | - | - | - | - |
| Total liabilities | 433 147,46 | 184 907,31 | 191 350,84 | 179 891,27 | 144 066,77 |
| A. Equity | -108 503,14 | -252 805,02 | -278 285,86 | -291 108,73 | -296 297,61 |
| B. Liabilities and provisions for liabilities | 541 650,60 | 437 712,33 | 469 636,70 | 471 000,00 | 440 364,38 |
| I. Long-term liabilities | 0,00 | - | - | - | - |
| II. Short-term liabilities | 541 650,60 | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.